IRADIMED CORP
IRMDUS売上高
$84M
百万USD
営業利益
$26M
百万USD
純利益
$22M
百万USD
ROE
23.8%
最新FY
EPS
$1.75
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $9M | $1M | $0.11 |
| FY2021 | Q2 | $10M | $1M | $0.12 |
| FY2021 | Q3 | $11M | $3M | $0.20 |
| FY2021 | FY | $42M | $9M | $0.74 |
| FY2022 | Q1 | $12M | $2M | $0.20 |
| FY2022 | Q2 | $13M | $3M | $0.26 |
| FY2022 | Q3 | $13M | $3M | $0.27 |
| FY2022 | FY | $53M | $13M | $1.02 |
| FY2023 | Q1 | $15M | $3M | $0.27 |
| FY2023 | Q2 | $16M | $4M | $0.33 |
| FY2023 | Q3 | $17M | $5M | $0.40 |
| FY2023 | FY | $66M | $17M | $1.35 |
| FY2024 | Q1 | $18M | $4M | $0.32 |
| FY2024 | Q2 | $18M | $5M | $0.38 |
| FY2024 | Q3 | $18M | $5M | $0.40 |
| FY2024 | FY | $73M | $19M | $1.50 |
| FY2025 | Q1 | $20M | $5M | $0.37 |
| FY2025 | Q2 | $20M | $6M | $0.45 |
| FY2025 | Q3 | $21M | $6M | $0.43 |
| FY2025 | FY | $84M | $22M | $1.75 |
| FY2026 | Q1 | $22M | $6M | $0.45 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $30M | $39M | $32M | $42M | $53M | $66M | $73M | $84M |
| 営業利益 | $11M | $1M | $6M | $9M | $-1M | $10M | $16M | $20M | $22M | $26M |
| 純利益 | $7M | $0M | $6M | $10M | $1M | $9M | $13M | $17M | $19M | $22M |
| 総資産 | $37M | $39M | $48M | $67M | $71M | $83M | $86M | $92M | $98M | $109M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $32M | $33M | $42M | $56M | $61M | $72M | $74M | $71M | $87M | $95M |
| 営業CF | - | $3M | $7M | $10M | $6M | $11M | $10M | $13M | $26M | $25M |
| EPS | $0.60 | $0.04 | $0.52 | $0.78 | $0.11 | $0.74 | $1.02 | $1.35 | $1.50 | $1.75 |
| BPS | $2.97 | $3.11 | $3.81 | $4.66 | $4.99 | $5.75 | $5.85 | $5.64 | $6.83 | $7.40 |
| ROE | 22.6% | 1.5% | 15.0% | 17.3% | 2.2% | 12.9% | 17.4% | 24.1% | 22.2% | 23.8% |